
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TransCelerate BioPharma Inc., has unveiled a new global campaign called "One Person Closer" designed to help increase awareness of the growing need for clinical trial participants. It has been seen that patients will not enroll into clinical trials without speaking to their healthcare provider first. This campaign focuses on inspiring that conversation in order to increase enrollment and thus helping meet the 58 million people demand of all enrolling studies on ClinicalTrials.gov
Read the full release






